The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy

被引:1
作者
Persson, C
Glimelius, B
机构
[1] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75183 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden
关键词
gastrointestinal cancer; quality of life; response; survival; weight loss;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Chemotherapy is frequently used for palliation inpatients with advanced gastrointestinal (GI) cancer and improvements in quality of life (QoL) and survival are documented. Several pre-treatment factors, particularly poor performance status, influence the outcomes. The relative importance of nutrition-associated factors is less well known. Patients and Methods: Data from 152 patients treated within four randomised studies were analysed to explore the relations between weight loss, nutrition-associated parameters, performance status, response to chemotherapy, global QoL and survival. Results: Patients with weight loss, poor performance, higher frequency of nutritional problems and low haemoglobin levels had a lower probability of responding to treatment. Global QoL was decreased in patients having weight loss as well as problems with pain or fatigue. Diagnosis had the strongest association to survival. In a multivariate analysis poor performance and weight loss were also independently related to survival. Conclusion: Weight loss and several nutrition-associated problems were associated with lower QoL, less likelihood to respond to chemotherapy and poor survival.
引用
收藏
页码:3661 / 3668
页数:8
相关论文
共 39 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES [J].
ALLENMERSH, TG ;
EARLAM, S ;
FORDY, C ;
ABRAMS, K ;
HOUGHTON, J .
LANCET, 1994, 344 (8932) :1255-1260
[3]   Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? [J].
Andreyev, HJN ;
Norman, AR ;
Oates, J ;
Cunningham, D .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (04) :503-509
[4]   Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis [J].
Buyse, M ;
Thirion, P ;
Carlson, RW ;
Burzykowski, T ;
Molenberghs, G ;
Piedbois, P .
LANCET, 2000, 356 (9227) :373-378
[5]  
Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO
[6]  
2-V
[7]  
Cella D, 1998, SEMIN ONCOL, V25, P43
[8]   PROGNOSTIC EFFECT OF WEIGHT-LOSS PRIOR TO CHEMOTHERAPY IN CANCER-PATIENTS [J].
DEWYS, WD ;
BEGG, C ;
LAVIN, PT ;
BAND, PR ;
BENNETT, JM ;
BERTINO, JR ;
COHEN, MH ;
DOUGLASS, HO ;
ENGSTROM, PF ;
EZDINLI, EZ ;
HORTON, J ;
JOHNSON, GJ ;
MOERTEL, CG ;
OKEN, MM ;
PERLIA, C ;
ROSENBAUM, C ;
SILVERSTEIN, MN ;
SKEEL, RT .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :491-497
[9]   Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer [J].
Glimelius, B ;
Linné, T ;
Hoffman, K ;
Larsson, L ;
Svensson, JH ;
Näsman, P ;
Svensson, B ;
Helmers, C .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :434-440
[10]   Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer [J].
Glimelius, B ;
Hoffman, K ;
Sjoden, PO ;
Jacobsson, G ;
Sellstrom, H ;
Enander, LK ;
Linne, T ;
Svensson, C .
ANNALS OF ONCOLOGY, 1996, 7 (06) :593-600